Benepali Surge And Imraldi Gains Drive Biogen Biosimilars Past US$500m

 
• By Dean Rudge
Car
The US$500m biosimilar sales barrier has been smashed by Biogen, with double-digit growth forecast in 2019 • Source: Shutterstock

More from Biosimilars

More from Products